PMC:7647877 / 77052-77333
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T866","span":{"begin":44,"end":57},"obj":"Body_part"}],"attributes":[{"id":"A866","pred":"fma_id","subj":"T866","obj":"http://purl.org/sig/ont/fma/fma9825"}],"text":"Studying microbiota and therefore the human immune system and its dysregulation, or controlling the effects of postbiotics in the symbiotic status represents an important opportunity to develop new drugs, and combining probiotic supplements, with vaccines and immunotherapies [16]."}
LitCovid-PD-UBERON
{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T174","span":{"begin":44,"end":57},"obj":"Body_part"}],"attributes":[{"id":"A174","pred":"uberon_id","subj":"T174","obj":"http://purl.obolibrary.org/obo/UBERON_0002405"}],"text":"Studying microbiota and therefore the human immune system and its dysregulation, or controlling the effects of postbiotics in the symbiotic status represents an important opportunity to develop new drugs, and combining probiotic supplements, with vaccines and immunotherapies [16]."}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1034","span":{"begin":38,"end":43},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T1035","span":{"begin":44,"end":57},"obj":"http://purl.obolibrary.org/obo/UBERON_0002405"}],"text":"Studying microbiota and therefore the human immune system and its dysregulation, or controlling the effects of postbiotics in the symbiotic status represents an important opportunity to develop new drugs, and combining probiotic supplements, with vaccines and immunotherapies [16]."}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T98419","span":{"begin":198,"end":203},"obj":"Chemical"}],"attributes":[{"id":"A58896","pred":"chebi_id","subj":"T98419","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"Studying microbiota and therefore the human immune system and its dysregulation, or controlling the effects of postbiotics in the symbiotic status represents an important opportunity to develop new drugs, and combining probiotic supplements, with vaccines and immunotherapies [16]."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T477","span":{"begin":0,"end":281},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Studying microbiota and therefore the human immune system and its dysregulation, or controlling the effects of postbiotics in the symbiotic status represents an important opportunity to develop new drugs, and combining probiotic supplements, with vaccines and immunotherapies [16]."}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"1683","span":{"begin":38,"end":43},"obj":"Species"}],"attributes":[{"id":"A1683","pred":"tao:has_database_id","subj":"1683","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Studying microbiota and therefore the human immune system and its dysregulation, or controlling the effects of postbiotics in the symbiotic status represents an important opportunity to develop new drugs, and combining probiotic supplements, with vaccines and immunotherapies [16]."}